BioNTech SE
BNTX
$99.47
$2.012.06%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -117.67% | -112.20% | -98.16% | -90.07% | -75.03% |
| Total Depreciation and Amortization | 60.12% | 70.79% | 55.63% | 52.77% | 10.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 145.41% | 162.10% | 141.85% | 35.27% | 42.77% |
| Change in Net Operating Assets | -73.00% | -60.21% | 22.72% | 5.57% | -4.33% |
| Cash from Operations | -71.95% | -66.99% | -31.62% | -59.35% | -56.58% |
| Capital Expenditure | -2.83% | 9.40% | 16.44% | 21.08% | -28.89% |
| Sale of Property, Plant, and Equipment | 166.68% | -64.55% | -- | -- | -92.40% |
| Cash Acquisitions | 100.00% | -- | -- | -- | -1,441.75% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.84% | -98.27% | -1,001.61% | -2,169.72% | -1,422.16% |
| Cash from Investing | -21.51% | -98.32% | -724.47% | -80,613.67% | -11,795.47% |
| Total Debt Issued | -33.33% | -50.00% | -62.50% | -62.50% | -50.00% |
| Total Debt Repaid | -36.46% | -38.26% | 0.26% | 32.55% | 62.55% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 99.90% | 73.36% | 64.01% | 25.13% | 14.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 93.78% | 68.26% | 71.18% | 42.55% | 38.56% |
| Foreign Exchange rate Adjustments | -725.33% | -112.75% | 225.41% | -119.28% | -107.43% |
| Miscellaneous Cash Flow Adjustments | 38,089.00% | 29,675.30% | 21,142.98% | 34,826.99% | -- |
| Net Change in Cash | -5,620.30% | -183.48% | -156.01% | -118.16% | -99.37% |
